February 1, 2023
Winter 2023 Newsletter
Thank you for reading our newsletter! We are proud to serve as a resource for…
February 1, 2023
NYSDOH Commissioner Determination on Telemedicine
The New York State Department of Health (NYSDOH) Acting Health Commissioner, Dr. James McDonald, issued…
January 20, 2023
MATTERS Deploying Harm Reduction Vending Machines Across NYS
The MATTERS Team plans to deploy 15 harm reduction vending machines across New York State…
January 13, 2023
X-Waiver: 2023 Updates
The passage of the MAT Act removed the requirement for DEA-licensed healthcare providers to undergo…
January 3, 2023
Passage of the MAT Act
The Mainstreaming Addiction Treatment (MAT) Act, included in the Omnibus Bill, was recently signed into…
December 9, 2022
Xylazine: An emerging public health concern
Xylazine, an animal tranquilizer, is making its way into opioids and other substances in the…
December 5, 2022
Opioid Prevention Program Data Report
The New York State Department of Health (NYSDOH) Opioid Prevention Program - Data to Action…
November 28, 2022
MATTERS: A model program with national potential
Thank you to the University at Buffalo Jacob's School of Medicine and Biomedical Sciences for…
October 25, 2022
Buprenorphine Access: Telehealth Revolution Faces Uncertain Future
October 25, 2022 By Morgan Godvin This summer, a young woman was revived by paramedics…
October 14, 2022
